IQVIA

OverviewSuggest Edit

IQVIA Holdings is a company that provides analytics, technology solutions, and contract research services. It focuses on a range of life science-related industries, including biopharma, MedTech, generics, consumer health, etc. The company was formed as a result of a merger between IMS Health and Quintiles.
TypePublic
Founded2016
HQDanbury, CT, US
Websiteiqvia.com
Employee Ratings3.9

Latest Updates

Employees (est.) (Dec 2021)79,000(+3%)
Job Openings22,355
Revenue (FY, 2021)$13.9 B(+23%)
Share Price (May 2022)$202
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at IQVIA

Ari Bousbib

Ari Bousbib

Chairman and Chief Executive Officer
Ron Bruehlman

Ron Bruehlman

Executive Vice President and Chief Financial Officer
Nick Childs

Nick Childs

Senior Vice President, Investor Relations and Corporate Communications
Trudy Stein

Trudy Stein

Executive Vice President and Chief Human Resources Officer
Karl Guenault

Karl Guenault

Senior Vice President and Chief Information Officer
Jim Berkshire

Jim Berkshire

Senior Vice President, Business Operations
Show more

IQVIA Office Locations

IQVIA has offices in Danbury, Durham, Hydra, Buenos Aires and in 102 other locations
Danbury, CT, US (HQ)
83 Wooster Heights
Durham, NC, US
4820 Emperor Blvd
Hydra, DZ
Cité Sellier, Coopérative Immobilière Mohamed, Boudiaf N°18, 1er étage
Buenos Aires, AR
7° piso, Av. Leandro N. Alem 1050
Melbourne, AU
Level 2/606 St Kilda Rd
Sydney, AU
Level 8, 201 Pacific Highway St Leonards
Show all (113)

IQVIA Financials and Metrics

IQVIA Revenue

Embed Graph
View revenue for all periods
IQVIA's revenue was reported to be $13.87 b in FY, 2021
USD

Revenue (Q1, 2022)

3.6b

Gross profit (Q1, 2022)

1.2b

Gross profit margin (Q1, 2022), %

34.9%

Net income (Q1, 2022)

325.0m

EBIT (Q1, 2022)

495.0m

Market capitalization (24-May-2022)

38.6b

Closing stock price (24-May-2022)

202.0

Cash (31-Mar-2022)

1.4b

EV

50.1b
IQVIA's current market capitalization is $38.6 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

11.1b11.4b13.9b

Revenue growth, %

6%2%

Cost of goods sold

7.3b7.5b9.2b

Gross profit

3.8b3.9b4.6b
Quarterly
USDQ1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021Q1, 2022

Revenue

2.8b2.5b2.8b3.4b3.4b3.4b3.6b

Cost of goods sold

1.8b1.7b1.8b2.3b2.3b2.3b2.3b

Gross profit

930.0m817.0m986.0m1.1b1.1b1.1b1.2b

Gross profit Margin, %

34%32%35%33%32%34%35%
Annual
USDFY, 2016FY, 2017FY, 2019FY, 2020FY, 2021

Cash

1.2b959.0m837.0m1.8b1.4b

Accounts Receivable

1.7b2.0b2.6b2.4b2.6b

Prepaid Expenses

123.0m146.0m138.0m159.0m156.0m

Current Assets

3.3b3.5b4.1b5.1b4.8b
Quarterly
Annual
USDFY, 2016FY, 2017FY, 2019FY, 2020FY, 2021

Net Income

130.0m1.3b227.0m308.0m971.0m

Depreciation and Amortization

289.0m1.0b1.2b1.3b1.3b

Accounts Payable

160.0m90.0m240.0m253.0m

Cash From Operating Activities

860.0m970.0m1.4b2.0b2.9b
USDFY, 2016

Debt/Equity

0.8 x

Debt/Assets

0.3 x

Financial Leverage

2.4 x
Show all financial metrics

IQVIA Operating Metrics

IQVIA's Customers was reported to be 10 k in FY, 2021. IQVIA's Backlog was reported to be $25.3b in Q1, 2022.
FY, 2016FY, 2017FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020Q3, 2020FY, 2020Q1, 2021Q2, 2021Q3, 2021FY, 2021Q1, 2022

Healthcare Workers

14 m15 m16 m20 m22 m23 m

Backlog

$17.13 b$17.58 b$18.03 b$18.3 b$19 b$19.6 b$20.5 b$21.7 b$22.6 b$23.2 b$23.9 b$24.4 b$24.8 b$25.3 b

Countries

828384100100100

Customers

5 k8 k8 k8 k10 k10 k

IQVIA Acquisitions / Subsidiaries

Company NameDateDeal Size
Q2 SolutionsApril 01, 2021$760 m
LinguamaticsFebruary 12, 2019
Advanced Health Media LLCMay 31, 2018
DrugDevNovember 16, 2017
Aileron SolutionsJuly 01, 2014
Novella Clinical LLCAugust 14, 2013
159 Solutions, LLC
159 Technology Solutions Private Ltd
Advanced Health Media Services Ltd.
AECIO IT Solutions India Private Ltd.
Show more

IQVIA Revenue Breakdown

Embed Graph

IQVIA revenue breakdown by business segment: 54.5% from Research & Development Solutions, 39.9% from Technology & Analytics Solutions and 5.7% from Contract Sales & Medical Solutions

IQVIA revenue breakdown by geographic segment: 49.4% from Americas, 31.4% from Europe and Africa and 19.2% from Asia-Pacific

IQVIA Cybersecurity Score

Cybersecurity ratingPremium dataset

C

77/100

SecurityScorecard logo

IQVIA Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

IQVIA Online and Social Media Presence

Embed Graph

IQVIA News and Updates

Global Precision Medicine Software Developers Market Research Report 2021-2031 with Profiles of Ariel Precision Medicine, C2i Genomics, Genedata, Inspirata,. IQVIA & SAP

DUBLIN, March 29, 2022 /PRNewswire/ -- The "Precision Medicine Software Developers Market by Target Therapeutic Indication, Key Geographical Regions and Types of End Users: Industry Trends and Global Forecasts, 2021-2031" report has been added to ResearchAndMarkets.com's offering. The...

Indian Clinical Trials Market Outlook to 2030 - Featuring Key Players Iqvia Holdings, Icon plc, PRA Health Sciences, Inc. and Syngene International Among Others

Dublin, March 11, 2022 (GLOBE NEWSWIRE) -- The "Indian Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design (Interventional Trials, Observational Trials, Expanded Access Trials), by Indication, and Segment Forecasts, 202…

IQVIA Announces Opening of New Q2 Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities

IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the opening of a state-of-the-art, 160,000-square-foot lab facility for its Q2 Solutions subsidiary.

Clalit HMO, Octopus.Health and IQVIA Introduce an AI-based Platform to Improve Patient Adherence to Treatment

Quality healthcare outcomes largely depend on patient adherence to recommended treatment regimens. Even more so when treating patients with chronic and complex conditions. Data from Clalit, Israel's largest HMO, shows that approximately 50% of its chronic patients do not adhere to their recommended …

Polpharma Selects IQVIA's Orchestrated Customer Engagement Platform to Improve Salesforce Productivity

IQVIA™, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that Polpharma Group BV, a leading Pharmaceutical Company in Rx and OTC medications, has selected IQVIA's Orchestrated Customer Engagement (OCE)…
Show more

IQVIA Frequently Asked Questions

  • When was IQVIA founded?

    IQVIA was founded in 2016.

  • Who are IQVIA key executives?

    IQVIA's key executives are Ari Bousbib, Ron Bruehlman and Nick Childs.

  • How many employees does IQVIA have?

    IQVIA has 79,000 employees.

  • What is IQVIA revenue?

    Latest IQVIA annual revenue is $13.9 b.

  • What is IQVIA revenue per employee?

    Latest IQVIA revenue per employee is $175.6 k.

  • Who are IQVIA competitors?

    Competitors of IQVIA include McKinsey, Infosys and LexisNexis Risk Solutions.

  • Where is IQVIA headquarters?

    IQVIA headquarters is located at 83 Wooster Heights, Danbury.

  • Where are IQVIA offices?

    IQVIA has offices in Danbury, Durham, Hydra, Buenos Aires and in 102 other locations.

  • How many offices does IQVIA have?

    IQVIA has 113 offices.